Back to company

CLINIGMA ApS: Financial statements 2024

CVR: 39350580

CLINIGMA ApS (CVR 39350580) has filed annual accounts for 2024. In 2024, the company reported a gross profit of DKK 3,187,953 and a net result of DKK -133,939 compared with DKK 2,346,088 the year before. That is a decrease of 48.9% compared with the year before. Equity amounted to DKK -2,130,643. The company had 7 employees in the financial year.

Gross Profit
3,187,953 kr.
Profit/Loss
-133,939 kr.
Equity
-2,130,643 kr.
Total Assets
11,561,224 kr.
Employees
7

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2024-3.2 mio.-134 t.-2.1 mio.7
2023-6.2 mio.2.3 mio.-1.2 mio.6
2022-2.9 mio.96 t.-3.6 mio.8
2021--60 t.-9.7 mio.-6.7 mio.8
2020-5.3 mio.2.8 mio.2.9 mio.4

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is CLINIGMA ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2024

CLINIGMA ApS: The 2023 annual report is outJun 28, 2024

CLINIGMA ApS has published its annual report for 2023. Gross profit came to DKK 6,233,952, and the net result was DKK 2,346,088.

About CLINIGMA ApS

CLINIGMA ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2018. The company is registered under the industry Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. The company was previously named Clinical Survey Outcomes ApS. The management consists of Christian Bredmose Holm. The company is owned by Kongsø Gruppen ApS and CH Technologies Holding ApS. In 2025, the company reported a gross profit of DKK 7,829,455 and a net result of DKK 2,200,115 compared with DKK -133,939 the year before. Equity amounted to DKK 69.

Other financial years